Article
FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodules
2025-01-24
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Differentiation between benign and malignant thyroid nodules has been a challenge in clinical practice. We aim to explore a novel biomarker to determine the malignancy of thyroid nodules. <bold>Materials and methods: </bold>In the discovery study, 32 tissue samples from benign thyroid nodule (BTN) and thyroid cancer (TC) patients were analyzed by Methylation 850...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 425d1b7d-c82b-5ee8-90a7-87814cfd0ad9
- DOI
- 10.21203/rs.3.rs-5794576/v1
